Related Experiment Video
Updated: Aug 9, 2026
04:47
Du-Moxibustion in a Mouse Model of Ankylosing Spondylitis
Published on: October 27, 2023
Current therapeutic practices in spondyloarthropathies
1Division of Rheumatology, University of Illinois College of Medicine, Peoria 61656.
Comprehensive Therapy
|February 1, 1988
Summary
Spondyloarthropathies, a group of spinal diseases, are best managed with exercise, NSAIDs, and physical therapy. Specific medications like indomethacin and corticosteroids are effective for associated arthritis.
Area of Science:
- Rheumatology
- Immunology
- Orthopedics
Background:
- Spondyloarthropathies encompass diverse diseases sharing spinal involvement (sacroiliitis), asymmetric peripheral arthritis, and HLA-B27 association.
- Key characteristics include absence of rheumatoid nodules and negative rheumatoid factor, differentiating them from other arthritic conditions.
Purpose of the Study:
- To outline the management strategies for spondylitis and associated peripheral arthritis.
- To highlight effective pharmacological and non-pharmacological interventions for spondyloarthropathies.
Main Methods:
- Review of current treatment guidelines and clinical practices for spondyloarthropathies.
- Analysis of the efficacy of non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and disease-modifying antirheumatic drugs (DMARDs).
Main Results:
- Regular exercise programs, physical therapy, and NSAIDs are crucial for spondylitis management.
- Indomethacin and phenylbutazone show high efficacy in Ankylosing Spondylitis (AS) and Reactive Spondylitis (RS), with caution advised for phenylbutazone.
- NSAIDs and intra-articular corticosteroids are primary treatments for peripheral arthritis; gold and cytotoxic drugs offer benefits in severe cases.
Conclusions:
- A multimodal approach combining exercise, physical therapy, and appropriate pharmacotherapy is essential for managing spondyloarthropathies.
- Treatment selection should be tailored to the specific disease subtype and severity, particularly for peripheral arthritis.
- Early and consistent management can improve outcomes for patients with spondylitis and related conditions.
More Related Videos
Related Concept Videos
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...